Diagnostic Pathology Course
Feb. 16, 2019
The University of Texas MD Anderson Cancer Center
South Campus Research Building
Conference Center, Floor 1, Rooms 1-6
7455 Fannin St.
Houston, TX 77030
6.50 AMA PRA Category 1 CreditsTM
Conf. #: D120866
The course will be of value to practicing pathologists and pathology trainees.
Agendas are subject to change because we are always striving to improve the quality of your educational experience. MD Anderson may substitute faculty with comparable expertise on rare occasions necessitated by illness, schedule conflicts and so forth.
Please let us know what specific topics, issues or questions you wish to see addressed or emphasized in this activity. Fax CME/Conference Management at 713-794-1724 or email email@example.com. All responses will be forwarded to the Program Chair for consideration.
This live activity will update general surgical pathologists on the application of current classification systems of solid neoplasms and precursor lesions. These include molecular classification of bladder tumors, evaluation of circulating tumor cell in lung cancer, classification of neurofibromatosis, classification of gastrointestinal tumors especially pancreatic endocrine neoplasms and mucinous cystic lesions, gynecologic tumors as well as thyroid neoplasms. There are many new molecular and genetic approaches that can be used to classify solid neoplasms.
This activity will also inform the target audience of the significant problematic diagnostic issues and provide them with the information needed to avoid making diagnostic errors when confronted with these scenarios. Research on recently implemented diagnostic and prognostic molecular tests will be presented as well, so attendees can use this information to improve the accuracy of their clinical and histopathologic diagnoses and classification.
The activity content is expected to increase the attendees' knowledge of the appropriate clinical use of diagnostic molecular testing, alter the attendees practice patterns to enable them to make more accurate diagnoses, and inform them of specific areas of diagnostic difficulty that will permit them to avoid diagnostic errors.
After attending the conference, participants should be able to:
- Apply updated diagnostic criteria and new molecular tests for proper classification and treatment of neoplastic lesions (knowledge, competence, performance, patient outcomes)
- Incorporate emerging and newly established biomarkers in classification of neoplasms and high risk lesions (knowledge, competence, performance, patient outcomes)
- Practice appropriate use of molecular testing and tumor diagnosis (knowledge, competence, performance)
A course evaluation form will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.
The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 6.50 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
CME Certificates and Attendance Verification Certificates
Certificates awarding AMA PRA Category 1 CreditTM or certificates documenting attendance will be emailed when an individual completes
the online CME Verification process after the conference.
The University of Texas MD Anderson Cancer Center has implemented a process whereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest that could potentially affect the information presented. MD Anderson also requires that all faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity.
General Registration Information
- On-site registration will open at 7:15 a.m. on Saturday, Feb. 16, 2019, in the foyer of the South Campus Research Building, 7455 Fannin St.
- The conference will begin at 8 a.m. on Saturday, Feb. 16, 2019, and will adjourn at 5:30 p.m.
- Advanced registration is encouraged as space and materials are limited.
Postmarked on or before Jan. 16, 2019
- Physicians: $250
- MD Anderson Physicians: $50
- Trainees/Students: $50
Postmarked after Jan. 16, 2019
- Physicians: $300
- MD Anderson Physicians: $75
- Trainees/Students: $50
Other Ways to Register Mail to:
CME/Conference Management, Unit 1781
The University of Texas MD Anderson Cancer Center
P.O. Box 301407Houston, TX 77230-1407
Fax to: 713-794-1724 (Printable Form)
We accept the following forms of payment:
- Check (payable through U.S. banks only)
- Money order
- Credit cards (MasterCard, Visa and American Express)
- Cash (on-site registration only)
If you register online, a receipt/confirmation letter will be automatically emailed to the email address you list on the registration form. If you register by fax or mail, a receipt/confirmation letter will be sent to you within 10 working daysof the receipt of your fee.
The registration fee, minus a $50 administrative handling fee, is refundable if a written request is received on or before Jan. 16, 2019. No refunds will be granted after that date. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check. For additional information, contact CME/Conference Management at 713-792-2223 or toll free at 866-849-5866 or email firstname.lastname@example.org.
The Department of CME/Conference Management reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary. Each registrant will be notified by mail, email or the contact numbers as given on the registration form.
In case of activity cancellation, liability of the Department of CME/Conference Management is limited to the registration fee. CME/Conference Management will refund the full registration fee.
The Department of CME/Conference Management reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available.
- A block of rooms has been reserved for conference attendees at the Houston Marriott Medical Center Hotel, 6580 Fannin St., Houston, Texas 77030.
- Early hotel reservation is suggested.
- The Marriott reservations phone number is 713-796-0080 or 800-228-9290.
- When you make reservation, be sure to mention Diagnostic Pathology Conference
- Request the Diagnostic Pathology Conference MD Anderson Room Block to receive the special meeting rate of $129.00 single or double occupancy. Please add 17% for state and local taxes.
- Reservations and deposits received after Friday, Jan. 18, 2019, will be confirmed if space is available and at current hotel published guest room rates.
Prices are subject to change and vary depending on the location of the conference.
- Houston is served by two airports, George Bush Intercontinental (IAH) and William P. Hobby (HOU).
- Taxicabs are available at an estimated cost of $50-60 to or from each airport.
- SuperShuttle operates a shuttle bus between George Bush Intercontinental Airport and the Houston Marriott Medical Center for $27 one-way and $54 round-trip. The shuttle between William P. Hobby Airport and the Houston Marriott Medical Center is $24 for one-way and the roundtrip cost is $48. For more information, call 713-523-8888 or toll-free at 800-258-3826.
Photographing, audio taping and videotaping are prohibited.